Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Weng

Showing results (151-160 of 295) with videos related to

Pageof 30
Sort By:
Journal of Diabetes and Its Complications|March 4, 2016
Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data poolOliver Schnell, Jianping Weng, Wayne H-H Sheu, et al.
Diabetes/Metabolism Research and Reviews|October 27, 2019
A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetesYingxin Xian, Haixia Xu, Yifang Gao, et al.
Frontiers in Immunology|December 30, 2022
High-risk genotypes for type 1 diabetes are associated with the imbalance of gut microbiome and serum metabolitesTong Yue, Huiling Tan, Chaofan Wang, et al.
Patient Preference and Adherence|September 12, 2014
Non-pharmaceutical factors for poor glycemic control in 13,970 Chinese women with drug-treated type 2 diabetes: a cross-sectional survey in 77 tertiary hospitals in four Chinese citiesJuming Lu, Jianping Weng, Weijun Gu, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 27, 2013
Worse pancreatic β-cell function and better insulin sensitivity in older Chinese without diabetesJianzhong Xiao, Jianping Weng, Linong Ji, et al.
Plos One|January 5, 2016
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B StudyXianghai Zhou, Linong Ji, Xingwu Ran, et al.
Diabetes & Metabolism Journal|September 1, 2021
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes MellitusQianwen Huang, Daizhi Yang, Hongrong Deng, et al.
Frontiers in Endocrinology|October 17, 2022
Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADASihui Luo, Tong Yue, Ziyu Liu, et al.
Diabetes|April 30, 2002
Contribution of known and unknown susceptibility genes to early-onset diabetes in scandinavia: evidence for heterogeneityCecilia M Lindgren, Elisabeth Widén, Tiinamaija Tuomi, et al.
Circulation Research|January 9, 2026
Neratinib, a Clinical Drug Against Breast Cancer, Protects Against Vascular Inflammation and AtherosclerosisFan-Shun Zhang, Chenyang He, Yanjun Yin, et al.
Pageof 30

Showing results (151-160 of 295) with videos related to

Sort By:
Pageof 30
Journal of Diabetes and Its Complications|March 4, 2016
Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data poolOliver Schnell, Jianping Weng, Wayne H-H Sheu, et al.
Diabetes/Metabolism Research and Reviews|October 27, 2019
A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetesYingxin Xian, Haixia Xu, Yifang Gao, et al.
Frontiers in Immunology|December 30, 2022
High-risk genotypes for type 1 diabetes are associated with the imbalance of gut microbiome and serum metabolitesTong Yue, Huiling Tan, Chaofan Wang, et al.
Patient Preference and Adherence|September 12, 2014
Non-pharmaceutical factors for poor glycemic control in 13,970 Chinese women with drug-treated type 2 diabetes: a cross-sectional survey in 77 tertiary hospitals in four Chinese citiesJuming Lu, Jianping Weng, Weijun Gu, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 27, 2013
Worse pancreatic β-cell function and better insulin sensitivity in older Chinese without diabetesJianzhong Xiao, Jianping Weng, Linong Ji, et al.
Plos One|January 5, 2016
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B StudyXianghai Zhou, Linong Ji, Xingwu Ran, et al.
Diabetes & Metabolism Journal|September 1, 2021
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes MellitusQianwen Huang, Daizhi Yang, Hongrong Deng, et al.
Frontiers in Endocrinology|October 17, 2022
Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADASihui Luo, Tong Yue, Ziyu Liu, et al.
Diabetes|April 30, 2002
Contribution of known and unknown susceptibility genes to early-onset diabetes in scandinavia: evidence for heterogeneityCecilia M Lindgren, Elisabeth Widén, Tiinamaija Tuomi, et al.
Circulation Research|January 9, 2026
Neratinib, a Clinical Drug Against Breast Cancer, Protects Against Vascular Inflammation and AtherosclerosisFan-Shun Zhang, Chenyang He, Yanjun Yin, et al.
Pageof 30